MGH-CP1
Catalog Number | Pack Size | List Price* | Quantity | |
---|---|---|---|---|
HY-139330-5MG | 5 mg | 102,00 | Add | |
HY-139330-10MG | 10 mg | 153,00 | Add | |
HY-139330-25MG | 25 mg | 317,00 | Add | |
HY-139330-50MG | 50 mg | 545,00 | Add | |
HY-139330-100MG | 100 mg | 875,00 | Add | |
HY-139330-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
MGH-CP1 is a potent and orally active TEAD2 and TEAD4 auto-palmitoylation inhibitor with IC50s of 710 nM and 672 nM, respectively. MGH-CP1 can decrease the palmitoylation levels of endogenous or ectopically expressed TEAD proteins in cells. MGH-CP1 can suppress Myc expression, inhibit epithelial over-proliferation, and induce apoptosis when together with Lats1/2 deletion[1].
Category | Biochemicals |
Supplier | MedChem Express |
Regulatory Status | RUO |
Research Field | Cancer, Apoptosis |
Format | Solubility: DMSO : 100 mg/mL (ultrasonic) |
Grade | Clinical information: No Development Reported |
Purity | 99.21% |
Molecular Formula | C20H24N4OS |
Molecular Weight | 368.5 |
CAS-Number | 896657-58-2 |
Storage Conditions | 4°C (Powder, sealed storage, away from moisture and light) |
Tech. Data Sheet | View datasheet |
Link To Supplier | http://www.medchemexpress.com |
Shipping Details | Room Temperature |
Material Safety Data Sheet | Download PDF |